Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$93.2M |
| 2 |
Automatic Data Processing
ADP
|
+$43.3M |
| 3 |
NCR Voyix
VYX
|
+$39M |
| 4 |
Visa
V
|
+$35.4M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$133M |
| 2 |
Meta Platforms (Facebook)
META
|
+$24.1M |
| 3 |
JD.com
JD
|
+$23.4M |
| 4 |
Bausch Health
BHC
|
+$17.5M |
| 5 |
AVNS
Avanos Medical
AVNS
|
+$14.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.36% |
| 2 | Technology | 11.17% |
| 3 | Industrials | 8.41% |
| 4 | Consumer Discretionary | 8.1% |
| 5 | Financials | 5.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $666M | 21.3% |
3,225,600
-430,700
| -12% | -$88.9M |
|
|
2
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $228M | 7.3% |
1,105,900
+209,100
| +23% | +$43.2M |
|
|
3
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33.1B
| $137M | 4.39% |
1,127,080
+768,239
| +214% | +$93.2M |
|
|
4
Automatic Data Processing
ADP
$112B
| $43M | 1.38% |
+502,292
| New | +$43.3M |
|
|
5
NCR Voyix
VYX
$1.09B
| $42.3M | 1.35% |
2,335,580
+2,243,371
| +2,433% | +$39M |
|
6
Pfizer
PFE
$160B
| $39.6M | 1.27% |
1,200,069
+793,752
| +195% | +$25.2M |
|
|
7
Visa
V
$693B
| $35M | 1.12% |
+534,640
| New | +$35.4M |
|
8
Workday
WDAY
$49.4B
| $34.3M | 1.1% |
406,246
+2,733
| +0.7% | +$231K |
|
|
9
Teva Pharmaceuticals
TEVA
$43.5B
| $34.3M | 1.1% |
+550,000
| New | +$32M |
|
10
Baidu
BIDU
$31.6B
| $33.3M | 1.07% |
159,738
+86,749
| +119% | +$18.6M |
|
11
iShares MSCI Japan ETF
EWJ
$22.4B
| $27.6M | 0.88% |
550,000
+450,000
| +450% | +$21.5M |
|
12
Eli Lilly
LLY
$1.12T
| $26.1M | 0.83% |
358,900
+148,100
| +70% | +$10.5M |
|
|
BCR
13
DELISTED
CR Bard Inc.
BCR
| $25.3M | 0.81% |
151,300
+117,934
| +353% | +$20.2M |
|
14
Elevance Health
ELV
$86.9B
| $24.2M | 0.78% |
156,900
+135,936
| +648% | +$19.4M |
|
15
Cardinal Health
CAH
$53.4B
| $23.8M | 0.76% |
264,086
+258,690
| +4,794% | +$22.3M |
|
16
Alphabet (Google) Class C
GOOG
$4.18T
| $23.6M | 0.75% |
853,778
+703,326
| +467% | +$18.8M |
|
17
CALL
Bristol-Myers Squibb
BMY
$137B
| $22.6M | 0.72% |
+350,000
| New | +$21.9M |
|
18
United Parks & Resorts
PRKS
$2.06B
| $22.1M | 0.71% |
1,148,085
+588,435
| +105% | +$10.8M |
|
19
Zimmer Biomet
ZBH
$19.3B
| $19.7M | 0.63% |
172,338
+166,836
| +3,032% | +$19M |
|
20
IBM
IBM
$222B
| $18.3M | 0.59% |
119,516
+93,755
| +364% | +$14.2M |
|
21
Lennox International
LII
$13.9B
| $17.9M | 0.57% |
160,000
-52,485
| -25% | -$5.41M |
|
22
Bread Financial
BFH
$4.07B
| $17.7M | 0.57% |
+74,848
| New | +$17.1M |
|
23
Tyson Foods
TSN
$20.6B
| $17.1M | 0.55% |
447,533
-221,867
| -33% | -$8.88M |
|
|
HRC
24
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $16.5M | 0.53% |
336,900
-42,200
| -11% | -$2.01M |
|
|
SPLK
25
DELISTED
Splunk Inc
SPLK
| $16.2M | 0.52% |
272,952
+10,883
| +4% | +$658K |
|
Similar funds
Paul Tudor Jones's Q1 2015 Portfolio in Review
As of Q1 2015, Paul Tudor Jones held 1,820 positions worth $3.13B, up 8.7% from $2.88B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Paul Tudor Jones deployed $200M of net new capital in Q1 2015, opening 403 new positions and adding to 483 existing holdings. Its largest new stake was Automatic Data Processing: 502,292 shares worth $43M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 10% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $24.1M trimmed.
- Paul Tudor Jones's largest Q1 2015 buy was Automatic Data Processing: 502,292 shares worth $43M.
- Paul Tudor Jones added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q1 2015, an estimated $93.2M increase.
- Paul Tudor Jones's biggest Q1 2015 reduction was Meta Platforms (Facebook), cutting an estimated $24.1M.
- Paul Tudor Jones fully exited State Street SPDR S&P 500 ETF Trust in Q1 2015, selling an estimated $133M.
- Paul Tudor Jones's ten largest holdings make up 41% of its $3.13B portfolio in Q1 2015.
- Paul Tudor Jones opened 403 new positions and closed 400 in Q1 2015.
- Paul Tudor Jones's portfolio value rose 8.7% quarter-over-quarter to $3.13B.
Based on Tudor Investment Corp's 13F filing for Q1 2015, filed 15 May 2015.